Broad expectations are for the budget deficit to push out by more than $1b from the budget forecast towards $15b for the year ...

Revenue: US$21.5b (up 11% from FY 2023). Net income: US$5.56b (up 2.4% from FY 2023). Profit margin: 26% (down from 28% in FY ...

EPS: US$2.84 (down from US$3.29 in FY 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period ...

EPS: US$0.58 (down from US$1.71 in FY 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period ...

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.6%.

The Federal Reserve could find it harder to balance growth and inflation next year, given the incoming Trump administration’s ...

The Olympics are known for the good sportsmanship and hospitality between different nations, but 2024 may change that forever ...

Though America's leading retirement program is in no danger of going bankrupt or becoming insolvent, the existing payout ...

From career and love to finances and health, these forecasts provide a glimpse into what the week ... However, refrain from ...

Ibuzatrelvir is a small molecule commercialized by Pfizer, with a leading Phase II program in Coronavirus Disease 2019 (COVID-19).

Eneboparatide is a recombinant peptide commercialized by AstraZeneca, with a leading Phase III program in Hypoparathyroidism.

Ferrari is expanding into luxury automotive market with strong growth and plans for 15 new models by 2026, but faces risks ...